Literature DB >> 668795

Pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. 11 Etidocaine.

D Morgan, D McQuillan, J Thomas.   

Abstract

The urinary elimination of etidocaine and several of its metabolites was investigated in neonates whose mothers had received one or more doses of etidocaine during labour. The urine collection period ranged among the neonates from 21.4 to 47.0 h post-partum. The total amounts of etidocaine and its metabolites recovered in neonatal urine represented a mean of 0.12% of the maternal dose. Some differences in the pattern of urinary metabolites were observed between neonates and adults. Mean half-life of elimination of etidocaine calculated from sigma-minus plots of the neonatal urinary data was 6.42 h. This is greater than that previously reported following intravenous administration of etidocaine to adults (2.6 h). The slower rate of elimination in neonates is probably due to an increased neonatal volume of distribution since there is evidence to show that etidocaine is extensively metabolised by the neonate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 668795     DOI: 10.1007/BF00644610

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Plasma binding and disposition of local anesthetics.

Authors:  G T Tucker
Journal:  Int Anesthesiol Clin       Date:  1975

2.  Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents.

Authors:  G T Tucker; L E Mather
Journal:  Br J Anaesth       Date:  1975-02       Impact factor: 9.166

3.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

4.  Plasma protein binding and placental transfer of bupivacaine.

Authors:  J Thomas; G Long; G Moore; D Morgan
Journal:  Clin Pharmacol Ther       Date:  1976-04       Impact factor: 6.875

5.  Anesthesia for cesarean section IV: placental transfer and neonatal elimination of bupivacaine following epidural analgesia for elective cesarean section.

Authors:  R Magno; A Berlin; K Karlsson; I Kjellmer
Journal:  Acta Anaesthesiol Scand       Date:  1976       Impact factor: 2.105

6.  Clearance and metabolism of mepivacaine in the human neonate.

Authors:  P Meffin; G J Long; J Thomas
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

7.  Disposition and placental transfer of etidocaine in pregnancy.

Authors:  D J Morgan; M J Cousins; D McQuillan; J Thomas
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

Review 8.  Clincial pharmacokinetics in neonates.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine.

Authors:  G W Mihaly; R G Moore; J Thomas; E J Triggs; D Thomas; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

  9 in total
  6 in total

Review 1.  Clinical pharmacokinetics of local anaesthetics.

Authors:  G T Tucker; L E Mather
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

2.  Etidocaine--a long-acting anesthetic agent. Review of the literature.

Authors:  D G Garcia
Journal:  Anesth Prog       Date:  1982 Jan-Feb

Review 3.  Drug kinetics in childbirth.

Authors:  R L Nation
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

4.  The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. III. Mepivacaine.

Authors:  R G Moore; J Thomas; E J Triggs; D B Thomas; E D Burnard; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

Review 5.  Obstetric analgesia. Clinical pharmacokinetic considerations.

Authors:  J Kanto
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 6.  Benefit and risks of local anesthetics in infants and children.

Authors:  Joel B Gunter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.